MAZE Stock Summary and Trading Ideas (Maze Therapeutics | NASDAQ:MAZE)

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

What symbol and exchange does Maze Therapeutics shares trade?

Maze Therapeutics trades on the NASDAQ stock market under the symbol MAZE.

What is Maze Therapeutics stock price doing today?

As of March 20, 2026, MAZE stock price climbed to $50.00 with 113,076 million shares trading.

What is Maze Therapeutics's Beta?

MAZE has a beta of 0.96, meaning it tends to be less sensitive to market movements. MAZE has a correlation of 0.04 to the broad based SPY ETF.

How much is Maze Therapeutics worth?

MAZE has a market cap of $2.40 billion. This is considered a Mid Cap stock.

How much money does Maze Therapeutics make?

Last quarter Maze Therapeutics reported $0 in Revenue and -$.66 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.05.

What are the top ETFs holding Maze Therapeutics?

The top ETF exchange traded funds that MAZE belongs to (by Net Assets): VTI, IWM, VXF, IBB, IWN.

Is Maze Therapeutics (MAZE) a good investment?

MAZE has outperformed the market in the last year with a price return of +311.9% while the SPY ETF gained +16.4%. MAZE has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +19.9% and +10.4%, respectively, while the SPY returned -4.1% and -4.2%, respectively.

What are the support and resistance levels for Maze Therapeutics (MAZE)?

MAZE support price is $47.35 and resistance is $51.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MAZE shares will trade within this expected range on the day.